Screening for Ovarian Cancer Not Recommended

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends against screening for ovarian cancer in women without symptoms and who are not known to be at high risk (such as those who have certain hereditary cancer syndromes that increase the risk for ovarian cancer).
 
Background: The USPSTF routinely makes recommendations about the effectiveness of preventive care services. This latest recommendation statement on screening for ovarian cancer is an update from 2012. Ovarian cancer is the fifth most common cause of cancer death among U.S. women, with approximately 14,000 deaths per year.
 
How: The USPSTF recommendation statement follows a review of evidence on the benefits and harms of screening for ovarian cancer in asymptomatic women not known to be at high risk for ovarian cancer.
 
 
 
 
Related material
 
The following related elements from The JAMA Network are also available on the For The Media website:
 
Screening for Ovarian Cancer – Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
 
— JAMA editorial: Screening for Ovarian Cancer in Asymptomatic Women
 
— JAMA Oncology editorial: The Yet Unrealized Promise of Ovarian Cancer Screening
 
— JAMA Internal Medicine editorial: Is There a Future for Ovarian Cancer Screening?
 
— JAMA Patient Page: Screening for Ovarian Cancer
 
Previously published by JAMA, The Hunt Continues for Early Ovarian Cancer Clues; Evolving Approaches in Research and Care for Ovarian Cancers.
 
For more details and to read the full report, please visit the For The Media website.
 
(doi:10.1001/jama.2017.21926)